Papers

1

Total Citations

8

H-Index

1

About

Im Sun Woo is a molecular biologist whose research centers on drug target identification and the mechanisms of bioactive compounds, with a particular focus on fission yeast as a model system. Her most notable contribution is the development and application of a genome-wide drug-induced haploinsufficiency screening approach in fission yeast, which she used to identify the cellular targets of hydrazinocurcumin (HC), a synthetic curcumin derivative with anti-angiogenic properties. This work, published in 2008 and cited 8 times, provided critical insights into the molecular mechanisms underlying HC's action, paving the way for the rational design of improved therapeutic compounds with enhanced pharmacological profiles. By leveraging the power of yeast genetics, Woo demonstrated an elegant strategy for elucidating drug mechanisms that can be applied to other bioactive molecules. Her research bridges chemical biology and functional genomics, offering a valuable platform for discovering how small molecules interact with cellular pathways. Woo's work continues to inform the development of next-generation curcumin-based therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Genome-wide drug-induced haploinsufficient screening of fission yeast for identification of hydrazinocurcumin targets.
8 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Korea Research Institute of Bioscience and Biotechnology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago